Mangroves are important ecosystems that support biodiversity, carbon sequestration, coastal defence and climate resilience. They also harbor a rich diversity of microbes that have potential applications in medicine and biotechnology. However, most of the mangrove microbial diversity remains unexplored and underutilized.

Mangrove microorganisms have proven to be an important source of medicine, food, feed, enzymes and antimicrobial substances

 (Lin et.al.2001; Maria et al.2005)

Mangrove microbes and their byproducts, known as postbiotics, offer promising opportunities to improve aquaculture. They enhance feed quality by providing beneficial substances that aid in nutrient digestion and absorption for aquatic animals. This leads to healthier, faster-growing organisms and more sustainable aquaculture practices. By promoting beneficial microbial communities, the reliance on antibiotics can be reduced, preventing antibiotic resistance and supporting eco-friendly aquaculture. Exploring the metabolic capabilities of mangrove microbes enables innovative approaches for enhancing the well-being, productivity, and sustainability of aquatic animals in restorative aquaculture.

In nature, bacteria are incredibly diverse and abundant, with estimates suggesting that there are trillions of individual bacterial cells present in just a single teaspoon of soil. However, it is important to note that only a small fraction of these bacteria, roughly around 1%, can be cultured or grown using traditional laboratory techniques. This phenomenon is known as the "great plate count anomaly" or "less than 1% problem."

​

Through the Miiiome™ Technology, the mangrove microbiome was studied, characterised and dissected using DNA, molecular and microbiological techniques to select the array of beneficial microbes that will greatly enhance the health and vitality of the fishes and other sea-life.